Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2017 / Pharma Pioneers / Davy Guillarme

Davy Guillarme

Senior Lecturer in the School of Pharmaceutical Sciences, University of Geneva/University of Lausanne, Geneva, Switzerland.

  • Profile

Meet Davy Guillarme

Motivation
My highest motivation is to help develop PhD and postdoc students in the field of analytical pharmaceutical chemistry. I’m also very pleased when I can present some interesting data obtained by my students at international conferences.

Luckiest break
I started my career with the development of analytical methods for small molecules. In 2012, we decided to evaluate the possibilities of chromatographic approaches (including LC, 2D-LC and LC-MS) for the analysis of protein biopharmaceuticals. Looking at the pharmaceutical market in 2017, I think we took a good decision at the right time, since a significant amount of R&D activity in the pharmaceutical industry is dedicated today to the analysis of large proteins.

Why pharmaceutical science?
Analytical techniques are widely used in the pharmaceutical industry, so there is always a need to develop some new analytical methods both for small molecules and protein biopharmaceuticals. In addition, when developing some new tools/methods for pharmaceutical analysis, I feel that I play a role in improving the safety of drugs.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.